Bruker PE ratio BRKR

Share price divided by earnings per share over the last twelve months, since 2012.

Today, Oct 23, 2026: n/m; losses over the last year
Last meaningful: 74.9×; Oct 2025
10-year median: 36.5×
10-year range: 22.5× to 84.2×
Peer median: 36.7×

Bruker has no meaningful PE ratio today: it lost $0.70 a share over the last twelve months, and a PE needs earnings.

It was last meaningful in Oct 2025, at 74.9×.

On the days it had one over the last ten years, its median was 36.5×, from 22.5× in Jul 2024 to 84.2× in Jul 2025.

PE ratio over time

median 36.5×

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2025	74.9×	22.8×	84.2×
2024	28.2×	22.5×	39.0×
2023	33.9×	26.6×	42.0×
2022	37.3×	27.4×	41.9×
2021	47.4×	44.4×	67.5×
2020	53.1×	26.0×	54.4×
2019	38.6×	32.7×	61.9×
2018	46.2×	31.8×	66.1×
2017	36.5×	23.1×	37.6×
2016	24.1×	24.1×	66.9×
2015	62.2×	47.3×	67.3×
2014	50.4×	40.1×	63.8×
2013	57.4×	25.8×	57.4×
2012	24.3×	20.4×	29.0×

Against its peers

Companies in Medical - Diagnostics & Research nearest Bruker's size, closest first, today.

Company	PE ratio
BRKRBruker	n/m
CAICaris Life Sciences	86.5×
BIOBio-Rad Laboratories	44.8×
LNTHLantheus	24.2×
BLLNBillionToOne	166×
RVTYRevvity	75.6×
MEDPMedpace	39.2×
VCYTVeracyte	34.2×
CDNACareDx	33.4×
LHLabcorp	27.2×
DGXQuest Diagnostics	25.7×
Peer median	36.7×

What the PE ratio tells you

Share price divided by earnings per share over the last twelve months. It is the price tag on a dollar of profit: 20× means you pay $20 for $1 of yearly earnings.

Blank while earnings are negative. A very low PE can mean the market expects profits to fall, so read it with growth and the company's own history.

More on Bruker

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.